BIOMAT Database Logo BIOMAT Database Logo

Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis. 2008

Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Department of Medicine, Dartmouth Medical School, Lebanon, NH 03756, USA. Sakhina.Haque-Begum@Dartmouth.EDU

T helper 17 (Th17) cells are pivotal in the immune pathogenesis of EAE. Glatiramer acetate (GA) can enhance Treg FOXp3 expression. We demonstrate that GA downregulates the expression of both IL-17 and IL-6 in two different EAE models. Increased mRNA expression in CNS for ROR gamma t, IL-17, IL-12/IL-23, IL-6, TNF-alpha, STAT4 and Th1 cytokines were significantly reduced by GA with a concomitant rise in SMAD3. The increased expression of TNF-alpha, IL-6, and IL-17 in CNS of CD25+ depleted animals was suppressed by GA treatment. This study demonstrates that both Th1 polarization and Th17 expression are modulated by GA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D005260 Female Females

Related Publications

Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis.
January 1990, European journal of immunology,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Methylprednisolone inhibits IFN-gamma and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis.
December 2009, Journal of neuroinflammation,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
June 2013, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
December 2004, Annals of the New York Academy of Sciences,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
August 2008, Proceedings of the National Academy of Sciences of the United States of America,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis.
January 2001, Journal of immunology (Baltimore, Md. : 1950),
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis.
August 2009, Journal of immunology (Baltimore, Md. : 1950),
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Downregulation of IL-17 and IFN-gamma in the optic nerve by beta-elemene in experimental autoimmune encephalomyelitis.
July 2010, International immunopharmacology,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.
April 1994, Journal of autoimmunity,
Sakhina Begum-Haque, and Alok Sharma, and Isaac R Kasper, and David M Foureau, and Daniel W Mielcarz, and Azizul Haque, and Lloyd H Kasper
Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
July 2022, ImmunoHorizons,
Copied contents to your clipboard!